APOBEC3G |
Q9HC16
|
apolipoprotein B mRNA editing enzyme catalytic subunit 3G
|
Enzyme
|
5.7E-21 |
0.653 |
0.346 |
BCL2 |
P10415
|
BCL2 apoptosis regulator
|
Signaling
|
0.56 |
0.291 |
0.885 |
BCL6 |
P41182
|
BCL6 transcription repressor
|
|
0.96 |
0.444 |
0.808 |
CCL2 |
P13500
|
C-C motif chemokine ligand 2
|
Signaling
|
0.61 |
0.321 |
0.962 |
CCR5 |
P51681
|
C-C motif chemokine receptor 5 (gene/pseudogene)
|
G-protein coupled receptor
|
4.3E-10 |
0.398 |
0.885 |
CD4 |
P01730
|
CD4 molecule
|
|
7.9E-04 |
0.604 |
0.654 |
CD9 |
P21926
|
CD9 molecule
|
|
4.7E-03 |
0.528 |
0.769 |
CHP1 |
Q99653
|
calcineurin like EF-hand protein 1
|
|
0.63 |
0.546 |
0.769 |
CR2 |
P20023
|
complement C3d receptor 2
|
|
4.7E-19 |
0.556 |
0.654 |
CXCL8 |
P10145
|
C-X-C motif chemokine ligand 8
|
Signaling
|
2.7E-04 |
0.310 |
0.962 |
CXCR4 |
P61073
|
C-X-C motif chemokine receptor 4
|
G-protein coupled receptor
|
1.8E-02 |
0.362 |
0.923 |
ERVK-18 |
|
endogenous retrovirus group K member 18
|
|
|
0.560 |
0.654 |
ERVK-20 |
|
endogenous retrovirus group K member 20
|
|
|
0.533 |
0.692 |
ERVK-32 |
|
endogenous retrovirus group K member 32, envelope
|
|
|
0.522 |
0.692 |
ERVW-1 |
Q9UQF0
|
endogenous retrovirus group W member 1, envelope
|
|
|
0.505 |
0.692 |
H3P19 |
|
H3 histone pseudogene 19
|
|
|
0.631 |
0.577 |
HLA-A |
P04439
|
major histocompatibility complex, class I, A
|
|
1.3E-03 |
0.370 |
0.846 |
HLA-B |
P01889
|
major histocompatibility complex, class I, B
|
|
3.9E-05 |
0.379 |
0.885 |
HLA-C |
P10321
|
major histocompatibility complex, class I, C
|
|
1.6E-06 |
0.415 |
0.846 |
HLA-DRB1 |
P01911
|
major histocompatibility complex, class II, DR beta 1
|
Immune response
|
1.1E-03 |
0.333 |
0.923 |
IFNA1 |
P01562
|
interferon alpha 1
|
|
|
0.371 |
0.923 |
IL10 |
P22301
|
interleukin 10
|
|
5.9E-03 |
0.281 |
0.923 |
IL17A |
Q16552
|
interleukin 17A
|
|
4.3E-02 |
0.324 |
0.923 |
IL1A |
P01583
|
interleukin 1 alpha
|
|
1.6E-04 |
0.333 |
0.962 |
IL1B |
P01584
|
interleukin 1 beta
|
|
0.13 |
0.276 |
0.962 |